venBio Global Strategic Fund III, L.P.

Insider Reports History

Location
San Francisco, CA
Signature
venBio Global Strategic Fund III, L.P., by: venBio Global Strategic GP III, L.P., its general partner, by: venBio Global Strategic GP III, Ltd., its general partner, by: /s/ Antoinette Delhonte, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by venBio Global Strategic Fund III, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
RayzeBio, Inc. 10%+ Owner Common Stock 5,158,162 $322,385,125 $62.50 19 Sep 2023 Direct
Elevation Oncology, Inc. 10%+ Owner Common Stock 1,905,430 $971,769 $0.5100 25 May 2022 Direct
Artiva Biotherapeutics, Inc. 10%+ Owner Common Stock 1,936,637 22 Jul 2024 Direct
Ventyx Biosciences, Inc. Other*, 10%+ Owner Stock Option (right to buy) 13,301 09 Jun 2022 Indirect
Artiva Biotherapeutics, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 22 Jul 2024 Direct
Artiva Biotherapeutics, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 22 Jul 2024 Direct
RayzeBio, Inc. 10%+ Owner Series A Convertible Preferred Stock 0 19 Sep 2023 Direct
RayzeBio, Inc. 10%+ Owner Series B Convertible Preferred Stock 0 19 Sep 2023 Direct
RayzeBio, Inc. 10%+ Owner Series C Convertible Preferred Stock 0 19 Sep 2023 Direct

Insider Reports Filed by venBio Global Strategic Fund III, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ARTV Artiva Biotherapeutics, Inc. 22 Jul 2024 6 +$4,999,992 4 10%+ Owner 22 Jul 2024, 20:26
ARTV Artiva Biotherapeutics, Inc. 18 Jul 2024 0 $0 3 10%+ Owner 18 Jul 2024, 20:14
/report/000090514823000957-venbio-global-strategic-fund-iii-l-p-2023-09-19 RayzeBio, Inc. 19 Sep 2023 6 $0 4 10%+ Owner 21 Sep 2023, 16:30
/report/000090514823000927-venbio-global-strategic-fund-iii-l-p-2023-09-14 RayzeBio, Inc. 14 Sep 2023 0 $0 3 10%+ Owner 14 Sep 2023, 20:37
VTYX Ventyx Biosciences, Inc. 09 Jun 2022 2 $0 4 Other*, 10%+ Owner 10 Jun 2022, 18:22
ELEV Elevation Oncology, Inc. 25 May 2022 1 -$2,897,806 4 10%+ Owner 27 May 2022, 19:20
VTYX Ventyx Biosciences, Inc. 25 Oct 2021 4 +$5,000,000 4 Other*, 10%+ Owner 25 Oct 2021, 19:40
VTYX Ventyx Biosciences, Inc. 20 Oct 2021 0 $0 3 Other*, 10%+ Owner 20 Oct 2021, 18:45
ELEV Elevation Oncology, Inc. 29 Jun 2021 3 +$10,000,000 4 10%+ Owner 01 Jul 2021, 17:27
ELEV Elevation Oncology, Inc. 24 Jun 2021 0 $0 3 10%+ Owner 24 Jun 2021, 18:03